Harpoon Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Harpoon Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2023.
  • Harpoon Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2023 was 1.85K %, a 683% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 1.85K +1.61K +683% Sep 30, 2023
Q2 2023 1.06K +877 +483% Jun 30, 2023
Q1 2023 599 +452 +309% Mar 31, 2023
Q4 2022 341 +201 +144% Dec 31, 2022
Q3 2022 236 +87.9 +59.4% Sep 30, 2022
Q2 2022 181 +17.6 +10.7% Jun 30, 2022
Q1 2022 146 -35.2 -19.4% Mar 31, 2022
Q4 2021 140 -25 -15.2% Dec 31, 2021
Q3 2021 148 +16 +12.1% Sep 30, 2021
Q2 2021 164 +73.6 +81.5% Jun 30, 2021
Q1 2021 182 +125 +220% Mar 31, 2021
Q4 2020 165 +124 +307% Dec 31, 2020
Q3 2020 132 +90.2 +216% Sep 30, 2020
Q2 2020 90.3 Jun 30, 2020
Q1 2020 56.8 Mar 31, 2020
Q4 2019 40.5 Dec 31, 2019
Q3 2019 41.8 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.